INTERNATIONAL PATENT: LEADERNA THERAPEUTICS, LTD., 成都先衍生物技术有限公司 FILES APPLICATION FOR "NUCLEIC ACID CONJUGATE HAVING DUAL-TARGET-GENE INHIBITORY EFFECT AND USE THEREOF"

GENEVA, Feb. 8 -- LEADERNA THERAPEUTICS, LTD. (Building 6, No. 8, Huigu 1st East Road, Tianfu International Bio-Town, Shuangliu DistrictChengdu, Sichuan 610219), 成都先衍生物技术有限公司 (中国四川省成都市双流区（天府国际生物城）慧谷东一路8号6栋) filed a patent application (PCT/CN2025/111290) for "NUCLEIC ACID CONJUGATE HAVING DUAL-TARGET-GENE INHIBITORY EFFECT AND USE THEREOF" on Jul 29, 2025. With publication no. WO/2026/026812, the details related to the patent application was published on Feb 05, 2026.

Nota...